Metabolic syndrome in prostate cancer: impact on risk and outcomes

Por Karzai, Fatima H, Madan, Ravi A, Dahut, William L
Publicado no Future Oncol (2016)

Beyond PSA: Managing Modern Therapeutic Options in Metastatic Castration-Resistant Prostate Cancer

Por Karzai, Fatima H., Madan, Ravi A., Figg, William D.
Publicado no South Med J (2015)

Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report

Por Shell, Jasmine, Patel, Dhaval, Powers, Astin, Quezado, Martha, Killian, Keith, Meltzer, Paul, Zhu, Jack, Gaitanidis, Apostolos, Karzai, Fatima, Neychev, Vladimir, Green, Patience, Kebebew, Electron
Publicado no J Endocr Soc (2017)

Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis

Por Troutman, Sarah M., Sissung, Tristan M., Cropp, Cheryl D., Venzon, David J., Spencer, Shawn D., Adesunloye, Bamidele A., Huang, Xuan, Karzai, Fatima H., Price, Douglas K., Figg, William D.
Publicado em 2012

A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening

Por Beshiri, Michael L., Tice, Caitlin M., Tran, Crystal, Nguyen, Holly M., Sowalsky, Adam G., Agarwal, Supreet, Jansson, Keith H., Yang, Qi, McGowen, Kerry M., Yin, JuanJuan, Alilin, Aian Neil, Karzai, Fatima H., Dahut, William L., Corey, Eva, Kelly, Kathleen
Publicado no Clin Cancer Res (2018)

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Por Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.
Publicado no J Immunother Cancer (2018)

Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer

Por Madan, Ravi A., Karzai, Fatima H., Ning, Yang-Min, Adesunloye, Bamidele A., Huang, Xuan, Harold, Nancy, Couvillon, Anna, Chun, Guinevere, Cordes, Lisa, Sissung, Tristan, Beedie, Shaunna L., Dawson, Nancy A., Theoret, Marc R., McLeod, David G., Rosner, Inger, Trepel, Jane B., Lee, Min-Jung, Tomita, Yusuke, Lee, Sunmin, Chen, Clara, Steinberg, Seth M., Arlen, Philip M., Gulley, James L., Figg, William D., Dahut, William L.
Publicado no BJU Int (2016)